Mirxes Nets HK$673 Million via Share Placement

MT Newswires Live02-06

Mirxes (HKG:2629) completed a placing of 21.9 million new shares at HK$32.50 each, generating net proceeds of about HK$673.4 million, according to a Thursday Hong Kong bourse filing.

Shares of the micro ribonucleic acid technology firm were down more than 4% in Friday morning trade.

The shares were placed to no fewer than six independent investors under a general mandate, the company said.

Mirxes said it plans to deploy the net proceeds toward investments and mergers and acquisitions, research and development, including clinical programs, expansion into emerging markets, and general working capital.

Following the placing, the issued share capital increased to 298.2 million shares, with the placees holding about 7.3% of the enlarged share base.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment